We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we ...

Kneat's SaaS model automates validation processes in pharma and biotech, reducing errors and ensuring compliance. Learn why ...

For some Big Pharma companies, sales in China contributed to more than 10 percent of global sales, making China a top market ...

CHINA DAILY Multinational pharmaceutical company AstraZeneca is bullish about China's role as a global innovation powerhouse, underpinned by the country's sound prospects as well as its growing ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

American pharmaceutical giant Johnson & Johnson (JNJ) is boosting its U.S. investments by 25% to more than $55 billion over ...

Johnson & Johnson has laid out plans to raise U.S. investments by 25% to more than $55 billion over the next four years, as a ...

Major American companies have complained to the White House trade office over Labor’s tax crackdown on multinationals amid ...

Investing in TSX healthcare stocks such as Kneat.com can help Canadians generate outsized gains in 2025 and beyond.

Starting at Rs 3,500 per injection, with a monthly cost of up to Rs 14,000, Mounjaro enters India’s growing diabetes and ...

The specialty chemicals sector has faced headwinds over the past year, but Q4 FY25 shows signs of stabilisation ...

Australians with chronic conditions could save more than $80 a year as plans to cut prescription medicine costs receive ...